| Year |
Citation |
Score |
| 2020 |
Yang S, Zeng K, Chen K, Zhao X, Wu J, Huang Y, Zhang M, Deng Z. Sequence Evolution, Abundance, and Chromosomal Distribution of Ty1-copia Retrotransposons in the Saccharum spontaneum Genome. Cytogenetic and Genome Research. PMID 32516773 DOI: 10.1159/000506222 |
0.315 |
|
| 2020 |
Sartor O, Yang S, Ledet E, Moses M, Nicolosi P. Inherited DNA-repair gene mutations in African American men with prostate cancer. Oncotarget. 11: 440-442. PMID 32064047 DOI: 10.18632/Oncotarget.27456 |
0.325 |
|
| 2020 |
Abou Alaiwi S, Nassar A, Adib E, Akl E, Groha S, Esplin ED, Nielsen S, Yang S, McGregor BA, Pomerantz M, Gusev A, Rana HQ, Sonpavde G, Garber JE, Freedman ML, et al. Prevalence of pathogenic germline risk variants (PVs) in 1,829 renal cell carcinoma (RCC) patients (pts). Journal of Clinical Oncology. 38: 659-659. DOI: 10.1200/Jco.2020.38.6_Suppl.659 |
0.333 |
|
| 2020 |
Ramamurthy C, Esplin ED, Yang S, Liss M, Tomlinson GE, Sonpavde G. Germline alterations in patients with testicular cancer. Journal of Clinical Oncology. 38: 397-397. DOI: 10.1200/Jco.2020.38.6_Suppl.397 |
0.316 |
|
| 2020 |
Nielsen SM, Szmulewitz RZ, Yang S, Truty R, Michalski ST, Das K, Ngo N, Alvarez DEP, Lincoln SE, Nussbaum RL, Esplin ED. Expansion of germline genetic testing criteria for prostate cancer yields findings across all stages of disease. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E17615 |
0.303 |
|
| 2020 |
Ngo N, Lincoln SE, Das K, Alvarez DEP, Yang S, Michalski ST, Nielsen SM, Esplin ED, Nussbaum RL. Clinical utility of germline genetic testing after tumor genomic testing in colorectal cancer patients. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E16089 |
0.382 |
|
| 2020 |
Das K, Lincoln SE, Ngo N, Alvarez DEP, Yang S, Michalski ST, Nielsen SM, Esplin ED, Nussbaum RL. Diagnostic yield of germline genetic testing following tumor testing in prostate cancer patients. Journal of Clinical Oncology. 38: 1591-1591. DOI: 10.1200/Jco.2020.38.15_Suppl.1591 |
0.31 |
|
| 2020 |
Lincoln SE, Das K, Ngo N, Nielsen SM, Michalski ST, Yang S, Alvarez DEP, Nussbaum RL, Esplin ED. Diagnostic yield and clinical utility of germline genetic testing following somatic testing in breast cancer patients. Journal of Clinical Oncology. 38: 1092-1092. DOI: 10.1200/Jco.2020.38.15_Suppl.1092 |
0.367 |
|
| 2020 |
Beitsch P, Whitworth P, Hughes K, Grady I, Barbosa K, Patel R, Kinney M, Baron P, Rosen B, Compagnoni G, Smith La, Simmons R, Coomer C, Holmes D, Brown E, ... ... Yang S, et al. Abstract P6-08-28: Comprehensive germline multigene panel testing changes clinical care for patients with breast cancer Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P6-08-28 |
0.341 |
|
| 2020 |
Lincoln SE, Pineda-Alvarez D, Michalski ST, Yang S, Esplin ED. Abstract P6-08-19: Germline mutation prevalence among US and non-US Hispanic patients undergoing genetic testing for breast and ovarian cancer predisposition Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P6-08-19 |
0.376 |
|
| 2020 |
Pineda-Alvarez DE, Michalski ST, Russell M, Yang S, Song IY, Nussbaum RL, Esplin ED. Abstract P2-09-08: Breast cancer tumor sequencing coupled with germline genetic testing aids the identification of at-risk individuals for hereditary breast cancer disorders Cancer Research. DOI: 10.1158/1538-7445.Sabcs19-P2-09-08 |
0.317 |
|
| 2020 |
Robinson K, Yang S, Li X, Ho Y, Beltran D, Murillo L, Harte R, Cargill M, Faulkner N, Nussbaum R. Tay-Sachs disease carrier screening: Comparative analysis of NGS-based sequencing and enzyme testing results Molecular Genetics and Metabolism. 129. DOI: 10.1016/J.Ymgme.2019.11.356 |
0.316 |
|
| 2019 |
Li DL, Yang Y, Yang S, Chen YK. The complete chloroplast genome sequence of (Pinaceae). Mitochondrial Dna. Part B, Resources. 4: 2934-2935. PMID 33365799 DOI: 10.1080/23802359.2019.1662749 |
0.352 |
|
| 2019 |
Nassar A, Mouw KW, Esplin ED, Yang S, Callis T, Nuzzo PV, Chanza NM, Choueiri TK, Kwiatkowski DJ, Sonpavde G. Germline alterations in urothelial carcinoma (UC) patients with family history of UC. Journal of Clinical Oncology. 37: 474-474. DOI: 10.1200/Jco.2019.37.7_Suppl.474 |
0.327 |
|
| 2019 |
Samadder J, Rupp M, Yang S, Michalski ST, Lincoln SE, Nussbaum RL, Borad MJ, Esplin ED. Landscape of germline mutations in hepatobiliary carcinoma: Unrealized risk, untapped clinical trial opportunities. Journal of Clinical Oncology. 37: 236-236. DOI: 10.1200/Jco.2019.37.4_Suppl.236 |
0.352 |
|
| 2019 |
Yang S, Michalski ST, Alvarez DEP, Lincoln SE, Whitworth PW, Nussbaum RL, Esplin ED. Comprehensive germline panel testing across cancer types: Diagnostic yield and clinical utility in 100,000 patient dataset. Journal of Clinical Oncology. 37. DOI: 10.1200/Jco.2019.37.15_Suppl.E13013 |
0.326 |
|
| 2019 |
Esplin ED, Yang S, Michalski ST, Alvarez DEP, Lincoln SE, Nussbaum RL. Germline multigene panel testing in colorectal cancer: Precision therapy and clinical management implications. Journal of Clinical Oncology. 37: 3582-3582. DOI: 10.1200/Jco.2019.37.15_Suppl.3582 |
0.313 |
|
| 2019 |
Beitsch PD, Whitworth PW, Hughes KS, Patel R, Baron P, Rosen B, Grady I, Holmes D, Simmons RM, Smith LA, Compagnoni G, Coomer CL, Brown EA, Barbosa K, Clark P, ... ... Yang S, et al. Comprehensive germline multigene panel testing changes clinical care for patients with breast cancer: Untapped clinical utility and PARP inhibitor trial eligibility. Journal of Clinical Oncology. 37: 1583-1583. DOI: 10.1200/Jco.2019.37.15_Suppl.1583 |
0.314 |
|
| 2019 |
Michalski ST, Alvarez DEP, Russell M, Yang S, Sonpavde G, Esplin ED. Tumor sequencing with germline genetic testing: Identification of patients with hereditary cancer and precision treatment eligibility. Journal of Clinical Oncology. 37: 1580-1580. DOI: 10.1200/Jco.2019.37.15_Suppl.1580 |
0.362 |
|
| 2019 |
Abou Alaiwi S, Nassar A, Mouw KW, Kwiatkowski DJ, Choueiri TK, Curran C, Van Allen EM, Esplin ED, Yang S, Garber JE, Rana HQ, Sonpavde G. Germline variants in urothelial carcinoma: Analysis of pathogenic and likely pathogenic variants in 645 subjects. Journal of Clinical Oncology. 37: 1528-1528. DOI: 10.1200/Jco.2019.37.15_Suppl.1528 |
0.356 |
|
| 2019 |
Beitsch P, Whitworth P, Baron P, Rosen B, Compagnoni G, Simmons R, Smith L, Holmes D, Brown E, Gold L, Clark P, Coomer C, Grady I, Barbosa K, Riley L, ... ... Yang S, et al. Abstract P5-09-06: Underdiagnosis of HBOC in breast cancer patients: Are genetic testing guidelines a tool or an obstacle? Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P5-09-06 |
0.336 |
|
| 2019 |
Beitsch P, Whitworth P, Baron P, Rosen B, Compagnoni G, Simmons R, Smith L, Holmes D, Brown E, Gold L, Clark P, Coomer C, Grady I, Barbosa K, Riley L, ... ... Yang S, et al. Abstract P5-09-03: Expanded panel testing superior to BRCA1/2 and breast cancer panel in patients with breast cancer Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P5-09-03 |
0.332 |
|
| 2019 |
Esplin E, Haverfield E, Yang S, Herrera B, Anderson M, Nussbaum R. Abstract P4-03-06: Limitations of direct-to-consumer genetic screening for HBOC: False negatives, false positives and everything in between Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P4-03-06 |
0.328 |
|
| 2019 |
Esplin ED, Yang S, Michalski S, Axilbund J, Lincoln SE, Nussbaum RL. Preparing for the unexpected: Panel-based testing of patients with uterine carcinoma reveals actionable variants in non-canonical genes Gynecologic Oncology. 154: 77-78. DOI: 10.1016/J.Ygyno.2019.04.183 |
0.309 |
|
| 2018 |
Beitsch PD, Whitworth PW, Hughes K, Patel R, Rosen B, Compagnoni G, Baron P, Simmons R, Smith LA, Grady I, Kinney M, Coomer C, Barbosa K, Holmes DR, Brown E, ... ... Yang S, et al. Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1801631. PMID 30526229 DOI: 10.1200/Jco.18.01631 |
0.33 |
|
| 2018 |
Yang S, Axilbund JE, O'Leary E, Michalski ST, Evans R, Lincoln SE, Esplin ED, Nussbaum RL. Underdiagnosis of Hereditary Breast and Ovarian Cancer in Medicare Patients: Genetic Testing Criteria Miss the Mark. Annals of Surgical Oncology. PMID 29998407 DOI: 10.1245/S10434-018-6621-4 |
0.34 |
|
| 2018 |
Blanco A, Yang S, Michalski S, Ouyang K, Hamlington B, Fulbright J, Erhard K, Kang H, Jacobs M, Koptiuch C, Vig H, Silver E, Benson C, Massingham L, Lincoln S, et al. Abstract P4-06-02: Germline analysis of breast cancer patients with abnormal somatic results: Ancillary assessment or critical co-diagnostic? Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P4-06-02 |
0.356 |
|
| 2017 |
Weile J, Sun S, Cote AG, Knapp J, Verby M, Mellor JC, Wu Y, Pons C, Wong C, van Lieshout N, Yang F, Tasan M, Tan G, Yang S, Fowler DM, et al. A framework for exhaustively mapping functional missense variants. Molecular Systems Biology. 13: 957. PMID 29269382 DOI: 10.15252/Msb.20177908 |
0.384 |
|
| 2017 |
O'Leary E, Iacoboni D, Holle J, Michalski ST, Esplin ED, Yang S, Ouyang K. Expanded Gene Panel Use for Women With Breast Cancer: Identification and Intervention Beyond Breast Cancer Risk. Annals of Surgical Oncology. PMID 28766213 DOI: 10.1245/S10434-017-5963-7 |
0.339 |
|
| 2017 |
Yang S, Lincoln SE, Kobayashi Y, Nykamp K, Nussbaum RL, Topper S. Sources of discordance among germ-line variant classifications in ClinVar. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 28569743 DOI: 10.1038/Gim.2017.60 |
0.311 |
|
| 2017 |
Kobayashi Y, Yang S, Nykamp K, Garcia J, Lincoln SE, Topper SE. Pathogenic variant burden in the ExAC database: an empirical approach to evaluating population data for clinical variant interpretation. Genome Medicine. 9: 13. PMID 28166811 DOI: 10.1186/S13073-017-0403-7 |
0.348 |
|
| 2017 |
Nussbaum RL, Yang S, Lincoln SE. Clinical Genetics Testing Laboratories Have a Remarkably Low Rate of Clinically Significant Discordance When Interpreting Variants in Hereditary Cancer Syndrome Genes. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016709451. PMID 28135136 DOI: 10.1200/Jco.2016.70.9451 |
0.329 |
|
| 2017 |
Yang S, Michalski ST, Holle J, Ekstein T, O'Leary E, Pardo C, Heidari N, Anderson M, Ouyang K, Nussbaum RL, Lincoln SE, Esplin ED. Unexpected germline mutations in a pan-cancer analysis including sarcoma, renal, and other cancers. Journal of Clinical Oncology. 35: 1584-1584. DOI: 10.1200/Jco.2017.35.15_Suppl.1584 |
0.349 |
|
| 2017 |
Esplin E, Yang S, Michalski ST, Ouyang K, Fulbright J, Hamlington B, Erhard K, Kang HC, Tejada C, Jacobs M, Lincoln SE, Nussbaum RL, Blanco A. Determining the clinical value of germline genetic testing coupled with tumor mutation profiling. Journal of Clinical Oncology. 35: 1577-1577. DOI: 10.1200/Jco.2017.35.15_Suppl.1577 |
0.383 |
|
| 2016 |
Esplin E, Vikstrom K, Munson RW, Ouyang K, Yang S, Lincoln SE. Critical co-diagnostic or ancillary assessment: Germline testing for patients with somatic tumor profiling. Journal of Clinical Oncology. 34. DOI: 10.1200/Jco.2016.34.15_Suppl.E13123 |
0.327 |
|
| 2016 |
Lincoln SE, Cline M, Yang S, Kobayashi Y, Zhang M, O'Leary E, Topper S, Paten B, Nussbaum R. Variant classifications in BRCA1 and BRCA2: A systematic analysis of interlaboratory concordance Journal of Clinical Oncology. 34: 1592-1592. DOI: 10.1200/Jco.2016.34.15_Suppl.1592 |
0.344 |
|
| 2016 |
Lincoln S, Nykamp K, Kobayashi Y, Yang S, Powers M, Anderson M, Monzon F, Topper S. Abstract P2-09-11: Consistency of pathogenicity determinations for hereditary cancer gene mutations Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P2-09-11 |
0.379 |
|
| 2015 |
Desmond A, Kurian AW, Gabree M, Mills MA, Anderson MJ, Kobayashi Y, Horick N, Yang S, Shannon KM, Tung N, Ford JM, Lincoln SE, Ellisen LW. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment. Jama Oncology. PMID 26270727 DOI: 10.1001/Jamaoncol.2015.2690 |
0.36 |
|
| 2015 |
Lincoln SE, Kobayashi Y, Anderson MJ, Yang S, Desmond AJ, Mills MA, Nilsen GB, Jacobs KB, Monzon FA, Kurian AW, Ford JM, Ellisen LW. A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients. The Journal of Molecular Diagnostics : Jmd. 17: 533-44. PMID 26207792 DOI: 10.1016/J.Jmoldx.2015.04.009 |
0.44 |
|
| 2015 |
Tan CA, Rabideau M, Cohen S, Yang S, Vikstrom K, Monzon FA. MG-107 Multiple pathogenic variants identified by next-generation sequencing hereditary cancer panel testing – a case report Journal of Medical Genetics. 52. DOI: 10.1136/Jmedgenet-2015-103578.7 |
0.365 |
|
| 2015 |
Vikstrom K, Yang S, Kurz R, Lincoln SE, Esplin ED. MG-115 Colorectal cancer patients with BRCA1 and BRCA2 mutations: Preparing for unexpected results Journal of Medical Genetics. 52: A6.2-A6. DOI: 10.1136/Jmedgenet-2015-103578.15 |
0.353 |
|
| 2015 |
Ellisen LW, Lincoln SE, Kurian AW, Desmond AJ, Yang S, Mills MA, Kobayashi Y, Monzon FA, Ford JM. MG-114 Clinical actionability of multi-gene panel tests for hereditary breast and ovarian cancer (HBOC) Journal of Medical Genetics. 52: A6.1-A6. DOI: 10.1136/Jmedgenet-2015-103578.14 |
0.348 |
|
| 2014 |
Baker M, Strongosky AJ, Sanchez-Contreras MY, Yang S, Ferguson W, Calne DB, Calne S, Stoessl AJ, Allanson JE, Broderick DF, Hutton ML, Dickson DW, Ross OA, Wszolek ZK, Rademakers R. SLC20A2 and THAP1 deletion in familial basal ganglia calcification with dystonia. Neurogenetics. 15: 23-30. PMID 24135862 DOI: 10.1007/S10048-013-0378-5 |
0.39 |
|
| 2012 |
Nickles D, Madireddy L, Yang S, Khankhanian P, Lincoln S, Hauser SL, Oksenberg JR, Baranzini SE. In depth comparison of an individual's DNA and its lymphoblastoid cell line using whole genome sequencing. Bmc Genomics. 13: 477. PMID 22974163 DOI: 10.1186/1471-2164-13-477 |
0.367 |
|
| 2011 |
Hedges DJ, Guettouche T, Yang S, Bademci G, Diaz A, Andersen A, Hulme WF, Linker S, Mehta A, Edwards YJ, Beecham GW, Martin ER, Pericak-Vance MA, Zuchner S, Vance JM, et al. Comparison of three targeted enrichment strategies on the SOLiD sequencing platform. Plos One. 6: e18595. PMID 21559511 DOI: 10.1371/Journal.Pone.0018595 |
0.369 |
|
| 2009 |
McKernan KJ, Peckham HE, Costa GL, McLaughlin SF, Fu Y, Tsung EF, Clouser CR, Duncan C, Ichikawa JK, Lee CC, Zhang Z, Ranade SS, Dimalanta ET, Hyland FC, Sokolsky TD, ... ... Yang S, et al. Sequence and structural variation in a human genome uncovered by short-read, massively parallel ligation sequencing using two-base encoding. Genome Research. 19: 1527-41. PMID 19546169 DOI: 10.1101/Gr.091868.109 |
0.433 |
|
| 2007 |
Gordon L, Yang S, Tran-Gyamfi M, Baggott D, Christensen M, Hamilton A, Crooijmans R, Groenen M, Lucas S, Ovcharenko I, Stubbs L. Comparative analysis of chicken chromosome 28 provides new clues to the evolutionary fragility of gene-rich vertebrate regions. Genome Research. 17: 1603-13. PMID 17921355 DOI: 10.1101/Gr.6775107 |
0.471 |
|
| 2007 |
Gibbs RA, Rogers J, Katze MG, Bumgarner R, Weinstock GM, Mardis ER, Remington KA, Strausberg RL, Venter JC, Wilson RK, Batzer MA, Bustamante CD, Eichler EE, Hahn MW, ... ... Yang SP, et al. Evolutionary and biomedical insights from the rhesus macaque genome. Science (New York, N.Y.). 316: 222-34. PMID 17431167 DOI: 10.1126/Science.1139247 |
0.577 |
|
| 2006 |
Huntley S, Baggott DM, Hamilton AT, Tran-Gyamfi M, Yang S, Kim J, Gordon L, Branscomb E, Stubbs L. A comprehensive catalog of human KRAB-associated zinc finger genes: insights into the evolutionary history of a large family of transcriptional repressors. Genome Research. 16: 669-77. PMID 16606702 DOI: 10.1101/Gr.4842106 |
0.409 |
|
| 2004 |
Makova KD, Yang S, Chiaromonte F. Insertions and deletions are male biased too: a whole-genome analysis in rodents. Genome Research. 14: 567-73. PMID 15059997 DOI: 10.1101/Gr.1971104 |
0.335 |
|
| 2004 |
Yang S, Smit AF, Schwartz S, Chiaromonte F, Roskin KM, Haussler D, Miller W, Hardison RC. Patterns of insertions and their covariation with substitutions in the rat, mouse, and human genomes. Genome Research. 14: 517-27. PMID 15059992 DOI: 10.1101/Gr.1984404 |
0.595 |
|
| 2004 |
Gibbs RA, Weinstock GM, Metzker ML, Muzny DM, Sodergren EJ, Scherer S, Scott G, Steffen D, Worley KC, Burch PE, Okwuonu G, Hines S, Lewis L, DeRamo C, Delgado O, ... ... Yang S, et al. Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature. 428: 493-521. PMID 15057822 DOI: 10.1038/Nature02426 |
0.73 |
|
| 2003 |
Hardison RC, Chiaromonte F, Kolbe D, Wang H, Petrykowska H, Elnitski L, Yang S, Giardine B, Zhang Y, Riemer C, Schwartz S, Haussler D, Roskin KM, Weber RJ, Diekhans M, et al. Global predictions and tests of erythroid regulatory regions. Cold Spring Harbor Symposia On Quantitative Biology. 68: 335-44. PMID 15338635 DOI: 10.1101/Sqb.2003.68.335 |
0.686 |
|
| 2003 |
Elnitski L, Hardison RC, Li J, Yang S, Kolbe D, Eswara P, O'Connor MJ, Schwartz S, Miller W, Chiaromonte F. Distinguishing regulatory DNA from neutral sites. Genome Research. 13: 64-72. PMID 12529307 DOI: 10.1101/Gr.817703 |
0.728 |
|
| 2003 |
Hardison RC, Roskin KM, Yang S, Diekhans M, Kent WJ, Weber R, Elnitski L, Li J, O'Connor M, Kolbe D, Schwartz S, Furey TS, Whelan S, Goldman N, Smit A, et al. Covariation in frequencies of substitution, deletion, transposition, and recombination during eutherian evolution. Genome Research. 13: 13-26. PMID 12529302 DOI: 10.1101/Gr.844103 |
0.717 |
|
| 2002 |
Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, Agarwal P, Agarwala R, Ainscough R, Alexandersson M, An P, Antonarakis SE, Attwood J, Baertsch R, Bailey J, ... ... Yang S, ... ... Yang SP, et al. Initial sequencing and comparative analysis of the mouse genome. Nature. 420: 520-62. PMID 12466850 DOI: 10.1038/Nature01262 |
0.721 |
|
| 2001 |
Chiaromonte F, Yang S, Elnitski L, Yap VB, Miller W, Hardison RC. Association between divergence and interspersed repeats in mammalian noncoding genomic DNA Proceedings of the National Academy of Sciences of the United States of America. 98: 14503-14508. PMID 11717405 DOI: 10.1073/Pnas.251423898 |
0.713 |
|
| Show low-probability matches. |